Preoperative Use of GLP-1 Agonists In some patients, particularly those with a higher BMI or medical comorbidities, initiating GLP-1 agonists before surgery can aid in weight loss to reduce surgical risk
Who Should Avoid It: Individuals with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or active pancreatitis
Clinicians should counsel patients that delaying GLP-1 initiation until generic availability carries its own health cost: prolonged weight-related metabolic dysfunction, increased cardiovascular risk, and delayed metabolic improvements
Mice were housed under stable conditions of temperature (22 2 C), humidity (20%), and light (12 h light/dark cycle), with free access to tap water and diet
J., Cao, X., Holland, D., Brubaker, P
Key research areas under investigation include: Receptor-ligand selectivity studies Transcriptional regulation of melanogenic pathways Eumelanin synthesis mechanisms cAMP-dependent gene expression Neurobiological signaling in CNS models Inflammation-associated molecular endpoints Metabolic pathway interrogation How does MT-1 work in research studies